The success of GLP-1 medications has made drugs like semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and orforglipron (Foundayo) seem like a magic bullet for weight loss. But using ...

Abstract: Dual-stage nanopositioning systems are highly appealing for nanomanipulation owing to their large range, high speed, and high accuracy. In this article, a novel parallel-actuation dual-stage ...

Vitamin B12 helps your body turn food into energy, supporting your metabolism. People with obesity often have lower levels of vitamin B12. Low B12 levels can cause fatigue and brain fog, making it ...

Copyright: © 2025 The Author(s). Published by Elsevier Ltd.

Four people sit around a table and talk. Franz Kranz’s lacerating play Mass is built from the simplest and least theatrical of ingredients. Yet in this production, thanks to the skill of director ...

What is that place? Where is it? “I am going to prepare a place for you,” Jesus said to his disciples (John 14:2). What did he mean? It’s Holy Thursday, the night before his crucifixion and death. The ...

Boehringer Ingelheim said on Tuesday its experimental obesity drug led to average weight ‌loss of up to 16.6% in a late-stage trial, as the unlisted German drugmaker seeks to ‌catch up with obesity ...

Zealand Pharma (ZLDPF) announced on Tuesday that its GLP-1 candidate, survodutide, developed with German drugmaker Boehringer Ingelheim, met the primary goals in a late-stage trial, generating up to ...

Boehringer Ingelheim’s glucagon/GLP-1 dual agonist has driven 16.6% weight loss at Week 76 of a phase 3 study. While the result fell short of the bar set by existing drugs, the German drugmaker is ...

FRANKFURT, April 28 (Reuters) - Boehringer Ingelheim said on Tuesday its experimental obesity drug led to average weight loss of up to 16.6% in a late-stage trial, as the ‌unlisted German drugmaker ...

The booster arrived by barge from Louisiana on Monday (April 27) after a journey of 900 miles (1,450 kilometers). When you purchase through links on our site, we may earn an affiliate commission. Here ...

The world title fight between Keyshawn Davis and Edwin De Los Santos no longer headlines at Scope Arena in Norfolk, VA on June 7. The 135-pound contest fell through after the champion missed weight by ...